Meliconi R, Facchini A, Miglio F, Trevisan A, Alberti A, Realdi G, Baraldini M, Gasbarrini G
Clin Sci (Lond). 1985 Feb;68(2):123-6. doi: 10.1042/cs0680123.
Anti-liver-specific protein (LSP) antibody and liver membrane autoantibody (LMA) have been evaluated in 88 patients with hepatitis B virus (HBV)-induced chronic liver disease by means of radioimmunoprecipitation and immunofluorescence. Among our patients, 38 presented circulating HBe antigen while 43 had HBe antibody and seven were negative for both. Anti-LSP was mainly found in HBeAg positive chronic active hepatitis (CAH), anti-HBe in positive CAH and in anti-HBe positive chronic persistent hepatitis (CPH). Similar prevalences of LMA (range 13-33%) were detected in the various groups studied. Taking into account the histological diagnosis of disease activity (periportal inflammation and piecemeal necrosis) no significant differences were found between active and inactive patients. Taking into account the HBeAg/anti-HBe status, no significant differences were found between the patients positive for 'e' antigen or 'e' antibody. Humoral autoimmune reactions may also play a role in HBV-induced chronic (active) liver disease irrespective of HBeAg/anti-HBe status and hence of the viral replication activity of the patients.
通过放射免疫沉淀法和免疫荧光法,对88例乙型肝炎病毒(HBV)引起的慢性肝病患者的抗肝特异性蛋白(LSP)抗体和肝细胞膜自身抗体(LMA)进行了评估。在我们的患者中,38例出现循环HBe抗原,43例有HBe抗体,7例两者均为阴性。抗LSP主要见于HBeAg阳性的慢性活动性肝炎(CAH),抗HBe见于阳性CAH和抗HBe阳性的慢性持续性肝炎(CPH)。在所研究的各个组中,LMA的患病率相似(范围为13% - 33%)。考虑到疾病活动的组织学诊断(汇管区周围炎症和桥接坏死),活动期和非活动期患者之间未发现显著差异。考虑到HBeAg/抗HBe状态,“e”抗原或“e”抗体阳性的患者之间未发现显著差异。体液自身免疫反应可能在HBV引起的慢性(活动性)肝病中也起作用,而与HBeAg/抗HBe状态无关,因此也与患者的病毒复制活性无关。